BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2810398)

  • 1. Patterns of proto-oncogene expression in human glioma cell lines.
    LaRocca RV; Rosenblum M; Westermark B; Israel MA
    J Neurosci Res; 1989 Sep; 24(1):97-106. PubMed ID: 2810398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human glial fibrillary acidic protein: complementary DNA cloning, chromosome localization, and messenger RNA expression in human glioma cell lines of various phenotypes.
    Bongcam-Rudloff E; Nistér M; Betsholtz C; Wang JL; Stenman G; Huebner K; Croce CM; Westermark B
    Cancer Res; 1991 Mar; 51(5):1553-60. PubMed ID: 1847665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of glial fibrillary acidic protein gene methylation in human malignant gliomas.
    Fukuyama K; Matsuzawa K; Hubbard SL; Dirks PB; Murakami M; Rutka JT
    Anticancer Res; 1996; 16(3A):1251-7. PubMed ID: 8702246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated c-myc messenger RNA in multiple myeloma cell lines.
    Fourney R; Palmer M; Ng A; Dietrich K; Belch A; Paterson M; Brox L
    Dis Markers; 1990; 8(3):117-24. PubMed ID: 1980237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of myelin basic protein and glial fibrillary acidic protein genes in human glial brain tumors].
    Dmytrenko VV; Boĭko OI; Shostak KO; Bilets'kyĭ AV; Malysheva TA; Shamaiev MI; Kliuchka VM; Rozumenko VD; Zozulia IuP; Kavsan VM
    Tsitol Genet; 2009; 43(1):28-35. PubMed ID: 19663312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of oligodendrocyte-associated genes in cell lines derived from human gliomas and neuroblastomas.
    Kashima T; Tiu SN; Merrill JE; Vinters HV; Dawson G; Campagnoni AT
    Cancer Res; 1993 Jan; 53(1):170-5. PubMed ID: 8416742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of ros oncogene in primary human astrocytomas and astrocytoma cell lines.
    Wu JK; Chikaraishi DM
    Cancer Res; 1990 May; 50(10):3032-5. PubMed ID: 2185878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors.
    Versnel MA; Hagemeijer A; Bouts MJ; van der Kwast TH; Hoogsteden HC
    Oncogene; 1988 Jun; 2(6):601-5. PubMed ID: 3290807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
    Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
    Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogene amplification in pediatric brain tumors.
    Wasson JC; Saylors RL; Zeltzer P; Friedman HS; Bigner SH; Burger PC; Bigner DD; Look AT; Douglass EC; Brodeur GM
    Cancer Res; 1990 May; 50(10):2987-90. PubMed ID: 2334901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated c-myc expression in childhood medulloblastomas.
    MacGregor DN; Ziff EB
    Pediatr Res; 1990 Jul; 28(1):63-8. PubMed ID: 2198527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and karyotypic characterization of a new cell line derived from human gliosarcoma.
    Westphal M; Haensel M; Mueller D; Laas R; Kunzmann R; Rohde E; Koenig A; Hoelzel F; Herrmann HD
    Cancer Res; 1988 Feb; 48(3):731-40. PubMed ID: 3275500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the L-myc gene is under positive control by short-lived proteins.
    Saksela K
    Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.
    Weller M; Malipiero U; Aguzzi A; Reed JC; Fontana A
    J Clin Invest; 1995 Jun; 95(6):2633-43. PubMed ID: 7539458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.